Fukutani, Y., Kurachi, K., Torisawa, Y., Miyata, K., Hayashi, M., Sasaki, K., . . . Tamura, K. Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity. BMC.
Chicago Style (17th ed.) CitationFukutani, Yuma, et al. Human IPSC-derived NK Cells Armed with CCL19, CCR2B, High-affinity CD16, IL-15, and NKG2D Complex Enhance Anti-solid Tumor Activity. BMC.
MLA (9th ed.) CitationFukutani, Yuma, et al. Human IPSC-derived NK Cells Armed with CCL19, CCR2B, High-affinity CD16, IL-15, and NKG2D Complex Enhance Anti-solid Tumor Activity. BMC.
Warning: These citations may not always be 100% accurate.